Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Medroxyprogesterone Acetate Suspension bulk supplier for pharma manufacturers

Medroxyprogesterone Acetate Suspension 150 mg/mL, 400 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 150 mg/mL, 400 mg/mL

Reference Brands: Depo-Provera®(US & EU); Depo-Progestin®(EU)

Category: Women's Health

Medroxyprogesterone Acetate Injection is a long-acting contraceptive and hormone therapy used for menstrual disorders and endometriosis. Available mainly as a 150 mg/mL intramuscular suspension (e.g., Depo-Provera®), it offers sustained release for effective women’s health management. Trusted across the US and EU, this injectable ensures compliance and convenience in clinical and family planning settings.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Medroxyprogesterone Acetate (MPA) Suspension Injection is a long-acting progestin widely used in women’s health for contraception, menstrual disorders, and endometriosis management. Available as an intramuscular injectable suspension, common strengths include 150 mg/mL for contraceptive use and 400 mg/mL for other therapeutic indications. Leading manufacturers in the US and EU produce GMP-certified formulations trusted by healthcare providers, clinics, and hospitals. The injection offers convenient, sustained-release progestin therapy, improving patient compliance and effective hormone regulation. It is an essential pharmaceutical product for women’s reproductive health management in clinical and outpatient settings.

Medroxyprogesterone Acetate Suspension — third party manufacturing & bulk supply

Medroxyprogesterone Acetate Suspension 150 mg/mL, 400 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Medroxyprogesterone Acetate Suspension is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Medroxyprogesterone Acetate Suspension listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Medroxyprogesterone Acetate Suspension →
Back to Listing

Frequently Asked Questions

Medroxyprogesterone Acetate Suspension is listed as Injection in 150 mg/mL, 400 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Medroxyprogesterone Acetate Suspension is referenced against Depo-Provera®(US & EU); Depo-Progestin®(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Somatropin

Strength:
5 mg/1.5 mL, 10 mg/1.5 mL, 15 mg/1.5 mL

Form: injection (prefilled syringe)

Reference Brands: Genotropin (EU), Norditropin (EU/India)

View Details
Nafarelin Acetate

Strength:
2 mg/mL

Form: Nasal Spray

Reference Brands: Synarel (USA)

View Details
Ospemifene

Strength:
60 mg

Form: Tablets

Reference Brands: Osphena (USA/EU)

View Details
Elagolix

Strength:
150 mg, 200 mg

Form: Tablets

Reference Brands: Orilissa (USA),

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.